Exelixis
EXEL
#1622
Rank
NZ$16.96 B
Marketcap
$60.61
Share price
2.47%
Change (1 day)
60.58%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no stock splits for this company